ZENDAL logo —  Biologicals and Vaccines for human and animal health

ZENDAL

Biologicals and Vaccines for human and animal health

Founded 1993 Spain Spain 174 employees Biopharma, Biotechnology +2

General Information

Company Name ZENDAL
Founded Year 1993
Location Spain Spain
Employees 174
Industries Biopharma, Biotechnology, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with ZENDAL. To contact ZENDAL, visit zendal.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ZENDAL compare?

A PDF of ZENDAL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ZENDAL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ZENDAL

ZENDAL is a business group of 7 companies focused on Biotechnology and it is engaged in the development, manufacturing, and marketing of Biological and Pharmaceutical products for both human and animal health. The company, founded in 1993, operates within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Its slogan "Biologicals and Vaccines for human and animal health" reflects its primary focus.

Zendal has positioned itself as a crucial player in disease prevention for both human and animal health utilizing Biotechnology. As the corporate brand of the group, it draws together seven companies dedicated to high added value products in the health sector: CZ Vaccines, Biofabri, Vetia, Petia vet health, Zinereo Pharma, Probisearch, and Bialactis.

The company's emphasis on Biotechnology underscores its potential to contribute to a healthier planet through innovative solutions for disease prevention and management. As a Venture Capital analyst, it is essential to track Zendal's evolution within the industry and monitor any potential investment opportunities that may arise in the future.

Business keywords: Pharmaceuticals, Vaccines, Animal Health, Human Health, Disease Prevention, Biological Products, Viral Diseases, Bacterial Diseases, Contract Manufacturing, Cell Therapy, Health Sector, Biofarmaceutica, Coronavirus, Microbacterias

No funding data available for ZENDAL yet.

ZENDAL Alternatives & Competitors

View All Alternatives
ZENDAL vs

Game-changing animal disease prevention with orally-delivered, RT stable, cost effective vaccines fo...

Series A
21 employees
Biotechnology, Health Care
ZENDAL vs

Pioneering the future of healthcare with innovative immunotherapeutics and vaccines for chronic and...

44 employees
Biotechnology, Health Care
ZENDAL vs

Designing Specialised Biotechnological Solutions for Animal Health

54 employees
Biotechnology, Pharmaceutical

FAQ About ZENDAL

Biologicals and Vaccines for human and animal health
ZENDAL was founded in 1993.
ZENDAL is headquartered in Spain.
ZENDAL operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Pharmaceuticals, Vaccines, Animal Health and Human Health.
ZENDAL has approximately 174 employees.
Top alternatives and competitors to ZENDAL include Mazen Animal Health - Oral Vaccines, United Biomedical, Inc. (UBI), Tréidlia Biovet, ViroVet, Testa Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZENDAL and Mazen Animal Health - Oral Vaccines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ZENDAL, https://bouncewatch.com/company/zendal, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes